PREDICTORS OF GOOD GLYCEMIC CONTROL AMONG TYPE II DIABETES PATIENTS IN PALESTINE
Â Objectives: The aim of this study is to assess glycemic control and its relationship with patient characteristics, health-care system factors, and self-care management in type II diabetes patients.
Methods: A retrospective cross-sectional study was conducted among 330 type II diabetes patients who met the inclusion criteria and whose medical records covered a period of 1 year. Data concerning patient characteristics, health-care system factors, self-care management, and available last reading of hemoglobin A1c (HbA1c) were collected through personal interviews and a medical recordsâ€™ review using structured questionnaires and data collection forms. Good glycemic control was defined as HbA1c â‰¤7%. To assess the results, the Statistical Package for Social Sciences (version 16) was used to undertake descriptive, univariate, and multivariate analyses.
Results: The meanÂ±standard deviation age was 60Â±9.7 years. More than half of the participants were male (51.2%), and the majority had additional chronic diseases (88.5%). Of the total 271 participants whose HbA1c levels have been monitored, 16.7% had good glycemic control. Multivariate analysis showed that unemployment was significantly related to a decreased odds of good glycemic control (odds ratio=0.34; 95% confidence interval=0.12-0.98; p<0.05).
Conclusion: The study noted that the proportion of patients with good glycemic control was low, a result comparable to studies from many countries. Further investigation and improvement of inappropriate health-care system factors and self-care management together with educational programs that emphasize the importance of self-care management and the health-care providersâ€™ role would be of great benefit in glycemic control.
2. World Health Organization. Use of Glycated Haemoglobin (Hba1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a Who Consultation - 13 August; 2014. Available from: http://www.who.int/diabetes/publications/diagnosis_diabetes2011/en.
3. Vijan S, Hayward RA. Treatment of hypertension in Type 2 diabetes mellitus: Blood pressure goals, choice of agents, and setting priorities in diabetes care. Ann Intern Med 2003;138(7):593-602.
4. World Health Organization. Management of Diabetes Mellitus Standards of Care and Clinical Practice Guidelines - 13 June; 2012. Available from: http://www.apps.who.int/iris/bitstream/10665/116245/1/dsa509.pdf.
5. Krentz AJ, Bailey CJ. Oral antidiabetic agents: Current role in type 2 diabetes mellitus. Drugs 2005;65(3):385-411.
6. Ashur ST, Shah SA, Bosseri S, Fah TS, Shamsuddin K. Glycaemic control status among Type 2 diabetic patients and the role of their diabetes coping behaviours: A clinic-based study in Tripoli, Libya. Libyan J Med 2016;11(1):31086.
7. Zyoud SH, Al-Jabi SW, Sweileh WM, Morisky DE. Relationship of treatment satisfaction to medication adherence: Findings from a cross-sectional survey among hypertensive patients in Palestine. Health Qual Life Outcomes 2013;11:191.
8. de Bruin SR, van Oostrom SH, Drewes HW, de Jong-van Til JT, Baan CA, Struijs JN. Quality of diabetes care in Dutch care groups: No differences between diabetes patients with and without co-morbidity. Int J Integr Care 2013;13:e057.
9. Nau DP, Pacholski AM. Impact of pharmacy care services on patientsâ€™ perceptions of health care quality for diabetes. J Am Pharm Assoc 2007;47(3):358-65.
10. NCQA/ADA Diabetes. Ncqa/Ada Diabetes Physician Recognition Program - 30 August; 2012. Available from: http://www.ncqa.org/programs/recognition/clinicians/diabetes-recognition-program-drp.
11. Albikawi ZF, Abuadas M. Diabetes self-care management behaviours among Jordanian type two diabetes patients. Am Int J Contemp Res 2015;5(3):87-95.
12. Sweileh WM, Zyoud SH, Abu Nabâ€™a RJ, Deleq MI, Enaia MI, Nassar SM, et al. Influence of patientsâ€™ disease knowledge and beliefs about medicines on medication adherence: Findings from a cross-sectional survey among patients with type 2 diabetes mellitus in Palestine. BMC Public Health 2014;14:94.
13. Jamous RM, Sweileh WM, Abu-Taha AS, Sawalha AF, Zyoud SH, Morisky DE. Adherence and satisfaction with oral hypoglycemic medications: A pilot study in Palestine. Int J Clin Pharm 2011;33(6):942-8.
14. Aday LA. Evaluating the Healthcare System: Effectiveness, Efficiency, and Equity. Chicago: Health Administration Press; 2004.
15. Akel M, Hamadeh G. Quality of diabetes care in a university health center in Lebanon. Int J Qual Health Care 1999;11(6):517-21.
16. Aiken LH, Sochalski J, Lake ET. Studying outcomes of organizational change in health services. Med Care 1997;35 11 Suppl: NS6-18.
17. Naing L, Winn T, Rusli BN. Practical issues in calculating the sample size for prevalence studies. Arch Orofac Sci 2006;1:9-14.
18. Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 7th ed. New York: John Wiley & Sons; 1999.
19. Singh AS, Masuku MB. Sampling techniques and determination of sample size in applied statistics research: An overview. Int J Econ Commer Manag 2014;2:1-22.
20. Daniel WW. Biostatistics: Basic concepts and methodology for the health sciences. New Jersey: John Wiley & Sons; 2010.
21. Palestinian Ministry of Health. Annual Health Report Palestine - 20 February; 2013. Available from: http://www.moh.ps/Content/Books/nbcgI6bZxmosmDSuKLtbaawjztq8IwQ5N9 1Y138fwjS62fZBq9m4Qi_CcymmeY82fpborVA7zMqOQ h4bFPeaMB4po PS5svvyLVEIRyeXzfBE8.pdf.
22. Bureau of Health Promotion DoH. Overview of Health Promotion in Taiwan - 4 June; 2013. Available from: http://www.pitt.edu/~super7/49011-50001/49111-49121.pdf.
23. DOH Taiwan. Community Volunteer and Diabetes Health Education Trial - 11 April; 2012. Available from: http://www.bhp.doh.gov.tw/snew/doc.
24. Toobert DJ, Glasgow RE. Assessing diabetes self-management: The summary of diabetes self-care activities questionnaire. Handbook of Psychology and Diabetes. Switzerland: Harwood Academic; 1994. p. 351-75.
25. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich) 2008;10(5):348-54.
26. Sweileh WM, Ihbesheh MS, Jarar IS, Sawalha AF, Abu Taha AS, Zyoud SH, et al. Differences in medication adherence, satisfaction and clinical symptoms in schizophrenic outpatients taking different antipsychotic regimens. Curr Drug Saf 2011;6(5):285-90.
27. Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complications 2010;24(2):84-9.
28. Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in management of diabetes mellitus. J Diabetes Metab Disord 2013;12(1):14.
29. World Health Organization. Technical Discussion on Medicine Prices and Access to Medicines in the Eastern Mediterranean Region - 5 November; 2014. Available from: http://www.applications.emro.who.int/docs/EM_RC54_Tech_Disc_1_en.pdf?ua=1.
30. Haffner SM; American Diabetes Association. Dyslipidemia management in adults with diabetes. Diabetes Care 2004;27 Suppl 1:S68-71.
31. Alonso-FernÃ¡ndez M, Mancera-Romero J, Mediavilla-Bravo JJ, Comas-Samper JM, LÃ³pez-Simarro F, PÃ©rez-Unanua MP, et al. Glycemic control and use of A1c in primary care patients with type 2 diabetes mellitus. Prim Care Diabetes 2015;9(5):385-91.
32. Miller PE, Perez V. Low-calorie sweeteners and body weight and composition: A meta-analysis of randomized controlled trials and prospective cohort studies. Am J Clin Nutr 2014;100(3):765-77.
33. Al-Rowais NA. Glycemic control in diabetic patients in King Khalid University Hospital (KKUH)-Riyadh-Saudi Arabia. Saudi Pharm J 2014;22(3):203-6.
34. Al-Sultan FA, Al-Zanki N. Clinical epidemiology of Type 2 diabetes mellitus in Kuwait. Kuwait Med J 2005;37(2):98-104.
35. Habib SS, Aslam M. Risk factors, knowledge and health status in diabetic patients. Saudi Med J 2003;24(11):1219-24.
36. Arafat M, Salam A, Arafat O. The association of Type 2 diabetes with obesity and other factors: In multinational community. Int J Pharm Pharm Sci 2014;6(9):257-60.
37. Soubra L, Nureddin H, Omar AG, Saleh M. Factors associated with hypertension prevalence and control among lebanese Type 2 diabetic patients. Int J Pharm Pharm Sci 2016;8(10):153-9.
38. Delavari A, Alikhani S, Nili S, Birjandi RH, Birjandi F. Quality of care of diabetes mellitus type II patients in Iran. Arch Iran Med 2009;12(5):492-5.
39. Valle T, Koivisto VA, Reunanen A, Kangas T, Rissanen A. Glycemic control in patients with diabetes in Finland. Diabetes Care 1999;22(4):575-9.
40. Verma M, Paneri S, Badi P, Raman PG. Effect of increasing duration of diabetes mellitus type 2 on glycated hemoglobin and insulin sensitivity. Indian J Clin Biochem 2006;21(1):142-6.
41. Spoelstra JA, Stolk RP, Cohen D, Klungel OH, Erkens JA, Leufkens HG, et al. Antipsychotic drugs may worsen metabolic control in type 2 diabetes mellitus. J Clin Psychiatry 2004;65(5):674-8.
42. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: A meta-analysis. Diabetes Care 2001;24:1069-78.
43. Chlebowy DO, Garvin BJ. Social support, self-efficacy, and outcome expectations: Impact on self-care behaviors and glycemic control in Caucasian and African American adults with type 2 diabetes. Diabetes Educ 2006;32(5):777-86.
44. Kaholokula JK, Haynes SN, Grandinetti A, Chang HK. Biological, psychosocial, and sociodemographic variables associated with depressive symptoms in persons with type 2 diabetes. J Behav Med 2003;26(5):435-58.
45. Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med 2005;118 Suppl 5A:27S-34.
46. Vijan S, Stuart NS, Fitzgerald JT, Ronis DL, Hayward RA, Slater S, et al. Barriers to following dietary recommendations in type 2 diabetes. Diabet Med 2005;22(1):32-8.
47. El-Kebbi IM, Cook CB, Ziemer DC, Miller CD, Gallina DL, Phillips LS. Association of younger age with poor glycemic control and obesity in Urban African Americans with type 2 diabetes. Arch Intern Med 2003;163(1):69-75.
48. Nichols GA, Hillier TA, Javor K, Brown JB. Predictors of glycemic control in insulin-using adults with type 2 diabetes. Diabetes Care 2000;23(3):273-7.
49. Rothenbacher D, RÃ¼ter G, Saam S, Brenner H. Younger patients with type 2 diabetes need better glycaemic control: Results of a community-based study describing factors associated with a high HbA1c value. Br J Gen Pract 2003;53(490):389-91.